Bank of America’s GoodRx Holdings GDRX Stock Holding History

Bank of America’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-63,500	Closed	-$269K	–	7727
2025 Q3	$269K	Buy	+63,500	New	+$279K	﹤0.01%	6136

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Bank of America's GDRX Position: Q1 2026 in Review

Bank of America sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 65,967 shares — an estimated $179K sold.

Bank of America first reported a position in GDRX in Q3 2020 and held it in 22 quarters. The position peaked at $12.8M in Q4 2021. 175 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

Bank of America reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
Bank of America sold 65,967 GoodRx Holdings shares in Q1 2026, an estimated $179K.
Bank of America first reported a position in GoodRx Holdings in Q3 2020 and held it in 22 quarters.
Bank of America's GoodRx Holdings position peaked at $12.8M in Q4 2021.
175 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.